<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34768771</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>21</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11340</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms222111340</ELocationID><Abstract><AbstractText>Olfactory dysfunction is considered an early prodromal marker of many neurodegenerative diseases. Neuropathological changes and aberrant protein aggregates occur in the olfactory bulb (OB), triggering a tangled cascade of molecular events that is not completely understood across neurological disorders. This study aims to analyze commonalities and differences in the olfactory protein homeostasis across neurological backgrounds with different spectrums of smell dysfunction. For that, an integrative analysis was performed using OB proteomics datasets derived from subjects with Alzheimer's disease (AD), Parkinson's disease (PD), mixed dementia (mixD), dementia with Lewy bodies (DLB), frontotemporal lobar degeneration (FTLD-TDP43), progressive supranuclear palsy (PSP) and amyotrophic lateral sclerosis (ALS) with respect to OB proteome data from neurologically intact controls. A total of 80% of the differential expressed protein products were potentially disease-specific whereas the remaining 20% were commonly altered across two, three or four neurological phenotypes. A multi-level bioinformatic characterization revealed a subset of potential disease-specific transcription factors responsible for the downstream effects detected at the proteome level as well as specific densely connected protein complexes targeted by several neurological phenotypes. Interestingly, common or unique pathways and biofunctions were also identified, providing novel mechanistic clues about each neurological disease at olfactory level. The analysis of olfactory epithelium, olfactory tract and primary olfactory cortical proteotypes in a multi-disease format will functionally complement the OB dyshomeostasis, increasing our knowledge about the neurodegenerative process across the olfactory axis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cartas-Cejudo</LastName><ForeName>Paz</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6182-7445</Identifier><AffiliationInfo><Affiliation>Clinical Neuroproteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Navarra Institute for Health Research, Universidad P&#xfa;blica de Navarra (UPNA), IdiSNA, 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lach&#xe9;n-Montes</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Neuroproteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Navarra Institute for Health Research, Universidad P&#xfa;blica de Navarra (UPNA), IdiSNA, 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Irigoyen</LastName><ForeName>Joaqu&#xed;n</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5072-4099</Identifier><AffiliationInfo><Affiliation>Clinical Neuroproteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Navarra Institute for Health Research, Universidad P&#xfa;blica de Navarra (UPNA), IdiSNA, 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santamar&#xed;a</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8046-8102</Identifier><AffiliationInfo><Affiliation>Clinical Neuroproteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Navarra Institute for Health Research, Universidad P&#xfa;blica de Navarra (UPNA), IdiSNA, 3, 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PID2019-110356RB- 259 I00/ AEI / 10.13039/501100011033</GrantID><Agency>Spanish Ministry of Science Innovation and Universities</Agency><Country/></Grant><Grant><GrantID>0011-1411-2020-000028</GrantID><Agency>Department of Economic and Business Development from Government of 260 Navarra</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009830" MajorTopicYN="N">Olfactory Bulb</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074702" MajorTopicYN="N">Proteostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013494" MajorTopicYN="N">Supranuclear Palsy, Progressive</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080874" MajorTopicYN="N">Synucleinopathies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">olfactory bulb</Keyword><Keyword MajorTopicYN="N">pathways</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>13</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34768771</ArticleId><ArticleId IdType="pmc">PMC8583219</ArticleId><ArticleId IdType="doi">10.3390/ijms222111340</ArticleId><ArticleId IdType="pii">ijms222111340</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mucke L. Alzheimer&#x2019;s disease. Nat. Cell Biol. 2009;461:895&#x2013;897. doi: 10.1038/461895a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/461895a</ArticleId><ArticleId IdType="pubmed">19829367</ArticleId></ArticleIdList></Reference><Reference><Citation>Koprich J.B., Kalia L.V., Brotchie J. Animal models of &#x3b1;-synucleinopathy for Parkinson disease drug development. Nat. Rev. Neurosci. 2017;18:515&#x2013;529. doi: 10.1038/nrn.2017.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2017.75</ArticleId><ArticleId IdType="pubmed">28747776</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R.L. Olfaction in Parkinson&#x2019;s disease and related disorders. Neurobiol. Dis. 2012;46:527&#x2013;552. doi: 10.1016/j.nbd.2011.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.10.026</ArticleId><ArticleId IdType="pmc">PMC3429117</ArticleId><ArticleId IdType="pubmed">22192366</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts R.O., Christianson T.J.H., Kremers W.K., Mielke M., Machulda M.M., Vassilaki M., Alhurani R.E., Geda Y.E., Knopman D.S., Petersen R.C. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia. JAMA Neurol. 2016;73:93&#x2013;101. doi: 10.1001/jamaneurol.2015.2952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.2952</ArticleId><ArticleId IdType="pmc">PMC4710557</ArticleId><ArticleId IdType="pubmed">26569387</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R.L. The olfactory vector hypothesis of neurodegenerative disease: Is it viable? Ann. Neurol. 2008;63:7&#x2013;15. doi: 10.1002/ana.21327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21327</ArticleId><ArticleId IdType="pubmed">18232016</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R.L. Olfactory dysfunction in neurodegenerative diseases: Is there a common pathological substrate? Lancet Neurol. 2017;16:478&#x2013;488. doi: 10.1016/S1474-4422(17)30123-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30123-0</ArticleId><ArticleId IdType="pubmed">28504111</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassar R., Chao S.K., Sitcheran R., Nu&#xf1;ez J.M., Vosshall L., Axel R. Topographic organization of sensory projections to the olfactory bulb. Cell. 1994;79:981&#x2013;991. doi: 10.1016/0092-8674(94)90029-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(94)90029-9</ArticleId><ArticleId IdType="pubmed">8001145</ArticleId></ArticleIdList></Reference><Reference><Citation>Soussi-Yanicostas N., de Castro F., Julliard A.K., Perfettini I., Chedotal A., Petit C. Anosmin-1, Defective in the X-Linked Form of Kallmann Syndrome, Promotes Axonal Branch Formation from Olfactory Bulb Output Neurons. Cell. 2002;109:217&#x2013;228. doi: 10.1016/S0092-8674(02)00713-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00713-4</ArticleId><ArticleId IdType="pubmed">12007408</ArticleId></ArticleIdList></Reference><Reference><Citation>De Castro F. Wiring olfaction: The cellular and molecular mechanisms that guide the development of synaptic connections from the nose to the cortex. Front. Neurosci. 2009;3:52. doi: 10.3389/neuro.22.004.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/neuro.22.004.2009</ArticleId><ArticleId IdType="pmc">PMC2858608</ArticleId><ArticleId IdType="pubmed">20582279</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomann P.A., Dos Santos V., Toro P., Sch&#xf6;nknecht P., Essig M., Schr&#xf6;der J. Reduced olfactory bulb and tract volume in early Alzheimer&#x2019;s disease&#x2014;A MRI study. Neurobiol. Aging. 2009;30:838&#x2013;841. doi: 10.1016/j.neurobiolaging.2007.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2007.08.001</ArticleId><ArticleId IdType="pubmed">17875348</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundi&#xf1;ano I.-C., Caballero M.-C., Ord&#xf3;&#xf1;ez C., Hernandez M., DiCaudo C., Marcilla I., Erro M.-E., Tu&#xf1;on M.-T., Luquin M.-R. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta Neuropathol. 2011;122:61&#x2013;74. doi: 10.1007/s00401-011-0830-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0830-2</ArticleId><ArticleId IdType="pubmed">21553300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundi&#xf1;ano I.-C., Hernandez M., DiCaudo C., Ordo&#xf1;ez C., Marcilla I., Tu&#xf1;on M.-T., Luquin M.-R. Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys. Acta Neuropathol. 2013;126:411&#x2013;425. doi: 10.1007/s00401-013-1144-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1144-3</ArticleId><ArticleId IdType="pubmed">23784261</ArticleId></ArticleIdList></Reference><Reference><Citation>Bathini P., Mottas A., Jaquet M., Brai E., Alberi L. Progressive signaling changes in the olfactory nerve of patients with Alzheimer&#x2019;s disease. Neurobiol. Aging. 2019;76:80&#x2013;95. doi: 10.1016/j.neurobiolaging.2018.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.12.006</ArticleId><ArticleId IdType="pubmed">30708185</ArticleId></ArticleIdList></Reference><Reference><Citation>Attems J., Walker L., Jellinger K.A. Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathol. 2014;127:459&#x2013;475. doi: 10.1007/s00401-014-1261-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1261-7</ArticleId><ArticleId IdType="pubmed">24554308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachen-Montes M., Morales A.G., Zelaya M.V., P&#xe9;rez-Valderrama E., Aus&#xed;n K., Ferrer I., Fern&#xe1;ndez-Irigoyen J., Santamar&#xed;a E. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer&#x2019;s disease progression. Sci. Rep. 2017;7:1&#x2013;15. doi: 10.1038/s41598-017-09481-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09481-x</ArticleId><ArticleId IdType="pmc">PMC5567385</ArticleId><ArticleId IdType="pubmed">28831118</ArticleId></ArticleIdList></Reference><Reference><Citation>Lach&#xe9;n-Montes M., Gonz&#xe1;lez-Morales A., Iloro I., Elortza F., Ferrer I., Gveric D., Fern&#xe1;ndez-Irigoyen J., Santamar&#xed;a E. Unveiling the olfactory proteostatic disarrangement in Parkinson&#x2019;s disease by proteome-wide profiling. Neurobiol. Aging. 2019;73:123&#x2013;134. doi: 10.1016/j.neurobiolaging.2018.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.09.018</ArticleId><ArticleId IdType="pubmed">30342273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lach&#xe9;n-Montes M., Gonz&#xe1;lez-Morales A., Schvartz D., Zelaya M.V., Ausin K., Fern&#xe1;ndez-Irigoyen J., S&#xe1;nchez J.C., Santamar&#xed;a E. The olfactory bulb proteotype differs across frontotemporal dementia spectrum. J. Proteom. 2019;201:37&#x2013;47. doi: 10.1016/j.jprot.2019.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2019.04.011</ArticleId><ArticleId IdType="pubmed">30999060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lach&#xe9;n-Montes M., &#xcd;&#xf1;igo-Marco I., Cartas-Cejudo P., Fern&#xe1;ndez-Irigoyen J., Santamar&#xed;a E. Olfactory Bulb Proteomics Reveals Widespread Proteostatic Disturbances in Mixed Dementia and Guides for Potential Serum Biomarkers to Discriminate Alzheimer Disease and Mixed Dementia Phenotypes. J. Pers. Med. 2021;11:503. doi: 10.3390/jpm11060503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11060503</ArticleId><ArticleId IdType="pmc">PMC8227984</ArticleId><ArticleId IdType="pubmed">34204996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lach&#xe9;n-Montes M., Mendizuri N., Ausin K., Andr&#xe9;s-Benito P., Ferrer I., Fern&#xe1;ndez-Irigoyen J., Santamar&#xed;a E. Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis. Int. J. Mol. Sci. 2020;21:8311. doi: 10.3390/ijms21218311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218311</ArticleId><ArticleId IdType="pmc">PMC7664257</ArticleId><ArticleId IdType="pubmed">33167591</ArticleId></ArticleIdList></Reference><Reference><Citation>Lach&#xe9;n-Montes M., Mendizuri N., Schvartz D., Fern&#xe1;ndez-Irigoyen J., S&#xe1;nchez J.C., Santamar&#xed;a E. Proteomic Characterization of the Olfactory Molecular Imbalance in Dementia with Lewy Bodies. Int. J. Mol. Sci. 2020;21:6371. doi: 10.3390/ijms21176371.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176371</ArticleId><ArticleId IdType="pmc">PMC7503830</ArticleId><ArticleId IdType="pubmed">32887355</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachen-Montes M., Fern&#xe1;ndez-Irigoyen J., Santamaria E. Deconstructing the molecular architecture of olfactory areas using proteomics. Proteom. - Clin. Appl. 2016;10:1178&#x2013;1190. doi: 10.1002/prca.201500147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.201500147</ArticleId><ArticleId IdType="pubmed">27226001</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Irigoyen J., Labarga A., Zabaleta A., De Morentin X.M., Perez-Valderrama E., Zelaya M.V., Santamar&#xed;a E. Toward defining the anatomo-proteomic puzzle of the human brain: An integrative analysis. Proteom. - Clin. Appl. 2015;9:796&#x2013;807. doi: 10.1002/prca.201400127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.201400127</ArticleId><ArticleId IdType="pubmed">25418211</ArticleId></ArticleIdList></Reference><Reference><Citation>Craft G.E., Chen A., Nairn A.C. Recent advances in quantitative neuroproteomics. Methods. 2013;61:186&#x2013;218. doi: 10.1016/j.ymeth.2013.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2013.04.008</ArticleId><ArticleId IdType="pmc">PMC3891841</ArticleId><ArticleId IdType="pubmed">23623823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitchen R.R., Rozowsky J., Gerstein M., Nairn A. Decoding neuroproteomics: Integrating the genome, translatome and functional anatomy. Nat. Neurosci. 2014;17:1491&#x2013;1499. doi: 10.1038/nn.3829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3829</ArticleId><ArticleId IdType="pmc">PMC4737617</ArticleId><ArticleId IdType="pubmed">25349915</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xda;beda-Ba&#xf1;&#xf3;n I., Saiz D., Flores-Cuadrado A., Rioja-Corroto E., Gonzalez-Rodriguez M., Villar-Conde S., Astillero-Lopez V., La Rosa J.P.C.-D., Gallardo-Alca&#xf1;iz M.J., Vaamonde-Gamo J., et al. The human olfactory system in two proteinopathies: Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Transl. Neurodegener. 2020;9:1&#x2013;20. doi: 10.1186/s40035-020-00200-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-020-00200-7</ArticleId><ArticleId IdType="pmc">PMC7271529</ArticleId><ArticleId IdType="pubmed">32493457</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Cuadrado A., Saiz-Sanchez D., Mohedano-Moriano A., Lamas-Cenjor E., Leon-Olmo V., Martinez-Marcos A., Ubeda-Ba&#xf1;on I. Astrogliosis and sexually dimorphic neurodegeneration and microgliosis in the olfactory bulb in Parkinson&#x2019;s disease. npj Park. Dis. 2021;7:1&#x2013;13. doi: 10.1038/s41531-020-00154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-00154-7</ArticleId><ArticleId IdType="pmc">PMC7820595</ArticleId><ArticleId IdType="pubmed">33479244</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey N.L., Wesson D.W., Brundin P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol. Dis. 2018;109:226&#x2013;248. doi: 10.1016/j.nbd.2016.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.12.013</ArticleId><ArticleId IdType="pmc">PMC5972535</ArticleId><ArticleId IdType="pubmed">28011307</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Cuadrado A., Saiz-Sanchez D., Moriano A.M., Martinez-Marcos A., Ubeda-Ba&#xf1;on I. Neurodegeneration and contralateral &#x3b1;-synuclein induction after intracerebral &#x3b1;-synuclein injections in the anterior olfactory nucleus of a Parkinson&#x2019;s disease A53T mouse model. Acta Neuropathol. Commun. 2019;7:56. doi: 10.1186/s40478-019-0713-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0713-7</ArticleId><ArticleId IdType="pmc">PMC6463651</ArticleId><ArticleId IdType="pubmed">30987677</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansouri A., Min W., Cole C.J., Josselyn S.A., Henderson J.T., Van Eede M., Henkelman R.M., Ackerley C., Grunebaum E., Roifman C.M. Cerebellar abnormalities in purine nucleoside phosphorylase deficient mice. Neurobiol. Dis. 2012;47:201&#x2013;209. doi: 10.1016/j.nbd.2012.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.04.001</ArticleId><ArticleId IdType="pubmed">22521465</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Esparcia P., L&#xf3;pez-Gonz&#xe1;lez I., Grau-Rivera O., Garc&#xed;a-Garrido M.F., Konetti A., Llorens F., Zafar S., Carmona M., del Rio J.A., Zerr I., et al. Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms. Front. Neurol. 2017;8:89. doi: 10.3389/fneur.2017.00089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00089</ArticleId><ArticleId IdType="pmc">PMC5346561</ArticleId><ArticleId IdType="pubmed">28348546</ArticleId></ArticleIdList></Reference><Reference><Citation>Esparcia P.G., Hern&#xe1;ndez-Ortega K., Ansoleaga B., Carmona M., Ferrer I. Purine metabolism gene deregulation in Parkinson&#x2019;s disease. Neuropathol. Appl. Neurobiol. 2015;41:926&#x2013;940. doi: 10.1111/nan.12221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12221</ArticleId><ArticleId IdType="pubmed">25597950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansoleaga B., Jov&#xe9; M., Schluter A., Esparcia P.G., Moreno J., Pujol A., Pamplona R., Portero-Ot&#xed;n M., Ferrer I. Deregulation of purine metabolism in Alzheimer&#x2019;s disease. Neurobiol. Aging. 2015;36:68&#x2013;80. doi: 10.1016/j.neurobiolaging.2014.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.08.004</ArticleId><ArticleId IdType="pubmed">25311278</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshihara Y., Kawasaki M., Tamada A., Fujita H., Hayashi H., Kagamiyama H., Mori K. OCAM: A New Member of the Neural Cell Adhesion Molecule Family Related to Zone-to-Zone Projection of Olfactory and Vomeronasal Axons. J. Neurosci. 1997;17:5830&#x2013;5842. doi: 10.1523/JNEUROSCI.17-15-05830.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.17-15-05830.1997</ArticleId><ArticleId IdType="pmc">PMC6573213</ArticleId><ArticleId IdType="pubmed">9221781</ArticleId></ArticleIdList></Reference><Reference><Citation>Puddifoot C.A., Wu M., Sung R.-J., Joiner W.J. Ly6h Regulates Trafficking of Alpha7 Nicotinic Acetylcholine Receptors and Nicotine-Induced Potentiation of Glutamatergic Signaling. J. Neurosci. 2015;35:3420&#x2013;3430. doi: 10.1523/JNEUROSCI.3630-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3630-14.2015</ArticleId><ArticleId IdType="pmc">PMC4339353</ArticleId><ArticleId IdType="pubmed">25716842</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng I., Lin Y.-C., Hwang E., Huang H.-T., Chang W.-H., Liu Y.-L., Chao C.-Y. Collagen VI protects against neuronal apoptosis elicited by ultraviolet irradiation via an Akt/Phosphatidylinositol 3-kinase signaling pathway. Neurosci. 2011;183:178&#x2013;188. doi: 10.1016/j.neuroscience.2011.03.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.03.057</ArticleId><ArticleId IdType="pubmed">21459131</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao J., Zhang Y., Chen X., Zhang J. The Roles of Peroxiredoxin 6 in Brain Diseases. Mol. Neurobiol. 2021;2021:1&#x2013;17. doi: 10.1007/s12035-021-02427-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02427-5</ArticleId><ArticleId IdType="pubmed">34013449</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou B., Pache L., Chang M., Khodabakhshi A.H., Tanaseichuk O., Benner C., Chanda S.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1&#x2013;10. doi: 10.1038/s41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Scolnick J.A., Cui K., Duggan C.D., Xuan S., Yuan X., Efstratiadis A., Ngai J. Role of IGF Signaling in Olfactory Sensory Map Formation and Axon Guidance. Neuron. 2008;57:847&#x2013;857. doi: 10.1016/j.neuron.2008.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.01.027</ArticleId><ArticleId IdType="pmc">PMC2364597</ArticleId><ArticleId IdType="pubmed">18367086</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Est&#xe9;vez V., Defterali &#xc7;., Vicario-Abej&#xf3;n C. IGF-I: A key growth factor that regulates neurogenesis and synaptogenesis from embryonic to adult stages of the brain. Front. Neurosci. 2016;10:52. doi: 10.3389/fnins.2016.00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00052</ArticleId><ArticleId IdType="pmc">PMC4763060</ArticleId><ArticleId IdType="pubmed">26941597</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Chen Z., Shang C., Yan F., Shi Y., Zhang J., Qu B., Han H., Wang Y., Li D., et al. IGF1-Dependent Synaptic Plasticity of Mitral Cells in Olfactory Memory during Social Learning. Neuron. 2017;95:106&#x2013;122.e5. doi: 10.1016/j.neuron.2017.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.06.015</ArticleId><ArticleId IdType="pmc">PMC5559288</ArticleId><ArticleId IdType="pubmed">28683263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader G.D., Hogue C.W.V. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 2003;4:2&#x2013;27. doi: 10.1186/1471-2105-4-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-4-2</ArticleId><ArticleId IdType="pmc">PMC149346</ArticleId><ArticleId IdType="pubmed">12525261</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H., Shim H., Shin D., Shim J.E., Ko Y., Shin J., Kim H., Cho A., Kim E., Lee T., et al. TRRUST: A reference database of human transcriptional regulatory interactions. Sci. Rep. 2015;5:11432. doi: 10.1038/srep11432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11432</ArticleId><ArticleId IdType="pmc">PMC4464350</ArticleId><ArticleId IdType="pubmed">26066708</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 2005;102:15545&#x2013;15550. doi: 10.1073/pnas.0506580102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Park G., Tan J., Garcia G., Kang Y., Salvesen G., Zhang Z. Regulation of Histone Acetylation by Autophagy in Parkinson Disease. J. Biol. Chem. 2016;291:3531&#x2013;3540. doi: 10.1074/jbc.M115.675488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.675488</ArticleId><ArticleId IdType="pmc">PMC4751393</ArticleId><ArticleId IdType="pubmed">26699403</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams G.P., Schonhoff A.M., Jurkuvenaite A., Thome A.D., Standaert D.G., Harms A.S. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson&#x2019;s disease. J. Neuroinflammation. 2018;15:244. doi: 10.1186/s12974-018-1286-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1286-2</ArticleId><ArticleId IdType="pmc">PMC6117927</ArticleId><ArticleId IdType="pubmed">30165873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickx D.M., Glaab E. Comparative transcriptome analysis of Parkinson&#x2019;s disease and Hutchinson-Gilford progeria syndrome reveals shared susceptible cellular network processes. BMC Med Genom. 2020;13:1&#x2013;16. doi: 10.1186/s12920-020-00761-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-020-00761-6</ArticleId><ArticleId IdType="pmc">PMC7437934</ArticleId><ArticleId IdType="pubmed">32811487</ArticleId></ArticleIdList></Reference><Reference><Citation>Cap K.C., Jung Y.-J., Choi B.Y., Hyeon S.J., Kim J.-G., Min J.-K., Islam R., Hossain A.J., Chung W.-S., Suh S.W., et al. Distinct dual roles of p-Tyr42 RhoA GTPase in tau phosphorylation and ATP citrate lyase activation upon different A&#x3b2; concentrations. Redox Biol. 2020;32:101446. doi: 10.1016/j.redox.2020.101446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101446</ArticleId><ArticleId IdType="pmc">PMC7264465</ArticleId><ArticleId IdType="pubmed">32046944</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Lee C., Kodama L., Gan L. Sex Differences in Neurodegeneration: The Role of the Immune System in Humans. Biol. Psychiatry. 2021 doi: 10.1016/j.biopsych.2021.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2021.01.002</ArticleId><ArticleId IdType="pmc">PMC8263798</ArticleId><ArticleId IdType="pubmed">33715827</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R.L., Shaman P., Applebaum S.L., Giberson R., Siksorski L., Rosenberg L. Smell Identification Ability: Changes with Age. Sci. 1984;226:1441&#x2013;1443. doi: 10.1126/science.6505700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6505700</ArticleId><ArticleId IdType="pubmed">6505700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachen-Montes M., Zelaya M.V., Segura V., Fern&#xe1;ndez-Irigoyen J., Santamaria E. Progressive modulation of the human olfactory bulb transcriptome during Alzheimer&#xb4;s disease evolution: Novel insights into the olfactory signaling across proteinopathies. Oncotarget. 2017;8:69663&#x2013;69679. doi: 10.18632/oncotarget.18193.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.18193</ArticleId><ArticleId IdType="pmc">PMC5642507</ArticleId><ArticleId IdType="pubmed">29050232</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M.S., Ahn S.B., Mohamedali A., Islam M.T., Cantor D., Verhaert P., Fanayan S., Sharma S., Nice E.C., Connor M., et al. Accelerating the search for the missing proteins in the human proteome. Nat. Commun. 2017;8:14271. doi: 10.1038/ncomms14271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14271</ArticleId><ArticleId IdType="pmc">PMC5286205</ArticleId><ArticleId IdType="pubmed">28117396</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari S., Sharma S., Ahn S.B., Baker M.S. In Silico Peptide Repertoire of Human Olfactory Receptor Proteomes on High-Stringency Mass Spectrometry. J. Proteome Res. 2019;18:4117&#x2013;4123. doi: 10.1021/acs.jproteome.8b00494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00494</ArticleId><ArticleId IdType="pubmed">31046287</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A., Birger C., Thorvaldsd&#xf3;ttir H., Ghandi M., Mesirov J.P., Tamayo P. The Molecular Signatures Database (MSigDB) Hallmark Gene Set Collection. Cell Syst. 2015;1:417&#x2013;425. doi: 10.1016/j.cels.2015.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC4707969</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens M., Ammar A., Riutta A., Waagmeester A., Slenter D.N., Hanspers K., Miller R.A., Digles D., Lopes E.N., Ehrhart F., et al. WikiPathways: Connecting communities. Nucleic Acids Res. 2020;49:D613&#x2013;D621. doi: 10.1093/nar/gkaa1024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1024</ArticleId><ArticleId IdType="pmc">PMC7779061</ArticleId><ArticleId IdType="pubmed">33211851</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabregat A., Jupe S., Matthews L., Sidiropoulos K., Gillespie M., Garapati P., Haw R., Jassal B., Korninger F., May B., et al. The Reactome Pathway Knowledgebase. Nucleic Acids Res. 2018;46:D649&#x2013;D655. doi: 10.1093/nar/gkx1132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1132</ArticleId><ArticleId IdType="pmc">PMC5753187</ArticleId><ArticleId IdType="pubmed">29145629</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M., Furumichi M., Tanabe M., Sato Y., Morishima K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353&#x2013;D361. doi: 10.1093/nar/gkw1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1092</ArticleId><ArticleId IdType="pmc">PMC5210567</ArticleId><ArticleId IdType="pubmed">27899662</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>